JSA advised Torreya Holdings LLC (Torreya) in relation to the India leg of 100% acquisition of Torreya Partners by Stifel Financial Corp. (Stifel). Torreya Partners India LLP, a subsidiary of Torreya Partners, is engaged in providing capital advisory services to pharma clients, primarily in India.
Torreya is a leading M&A and private capital advisory firm and is primarily engaged in advising pharma companies. Torreya specializes in the life sciences sector including biotechnology and pharmaceuticals. In addition to M&A, Torreya also offers advisory services with respect to joint ventures, royalty monetization, licensing agreements, and private capital raising. Stifel is a financial services company engaged in providing banking, securities, and financial services to clients across the globe. The acquisition is aimed at broadening Stifel’s business and expanding its reach in the pharma sector.
Our Transaction Team Comprised Lead Partner – Rupinder Malik, Partner – Rajul Bohra, Senior Associate – Abin Francis, and Associate – Sanchita Kumari.
Our Tax Team Comprised Partner & Head of Practice – Direct Tax – Kumarmanglam Vijay, and Senior Associate – Divyam Mittal.
